Review Article Open Access
Volume 2 | Issue 3 | DOI: https://doi.org/10.33696/immunology.2.030
CD146-Positive Tumors are Associated with Venous Thromboembolism
A. Joshkon1, J. Stalin1, W. Traboulsi1, L. Vivancos-Stalin1, M. Nollet1, R. Lacroix1, R.Bachelier1, F. Dignat-George1, A. Bertaud1, A.S. Leroyer1, H. Fayyad-Kazan2, N. Bardin1, M.Blot-Chabaud1,*
- 1Aix-Marseille University, INSERM, INRAE, C2VN, UFR Pharmacie, 27 Bd J. Moulin, 13005 Marseille, France
- 2Laboratory of Cancer Biology and Molecular Immunology, Lebanese University-Faculty of Science, Hadath, Lebanon
Corresponding Author
Marcel Blot-Chabaud, marcel.blot-chabaud@laposte.net
Received Date: April 02, 2020
Accepted Date: April 22, 2020
Joshkon A, Stalin J, Traboulsi W, Vivancos-Stalin L, Nollet M, Lacroix R, et al. CD146-Positive Tumors are Associated with Venous Thromboembolism. J Cell Immunol. 2020; 2(3): 116-123.
Copyright: © 2020 Joshkon A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
The role of CD146 and its soluble form have been intensely reviewed in the processes of cancer and inflammation. However, how CD146 is linked to coagulation and thrombotic events remains unclear. The aim of this paper is to shed light on this topic and clarify the contribution of CD146 as a procoagulant factor.
Recommended Articles
The Effect of Glucocorticoids on Angiogenesis in the Treatment of Solid Tumors
Glucocorticoids (GCs) are defined by their role in maintaining glucose homeostasis and natural GCs are a class of corticosteroids secreted by the adrenal cortex. Cortisol is the most important natural GC in humans. Cellular cortisol levels are regulated by the tissue-specific metabolic enzymes 11β-hydroxysteroid dehydrogenase 1 and 2 (11β-HSD 1 and 2); 11β-HSD 1 converts inactive cortisone to active cortisol, while 11β-HSD 2 has the opposite function.
Small-molecule Interferon Inducers for Cancer Immunotherapy Targeting Non-T cell-inflamed Tumors
Since the discovery of escaping mechanism of tumor from negative immune regulation, the paradigm of drug discovery for anti-cancer agents has been dramatically shifted to cancer immunotherapy (e.g., dendritic cell therapy, CAR-T cell therapy, or antibody therapy) by stimulating patient’s immune system to treat cancer.
CD146-Positive Tumors are Associated with Venous Thromboembolism
The role of CD146 and its soluble form have been intensely reviewed in the processes of cancer and inflammation. However, how CD146 is linked to coagulation and thrombotic events remains unclear. The aim of this paper is to shed light on this topic and clarify the contribution of CD146 as a procoagulant factor.
Repurposing of an Antifungal Drug against Gastrointestinal Stromal Tumors
Molecular docking approaches explore the receptor-ligand conformations within the binding sites of macromolecular targets [1]. Structure-based drug discovery is widely used by the scientific community in Medicinal Chemistry to estimate the ligand-receptor binding free energy by evaluating critical phenomena involved in the intermolecular recognition process [2,3].
TTK: A Promising Target in Malignant Tumors
TTK is a dual-specific protein kinase that phosphorylates serine and threonine. The spindle assembly checkpoint (SAC) acts as a molecular monitoring mechanism that regulates mitosis and ensures accurate separation of chromosomes. TTK is a key regulator of the SAC. Activated TTK localizes to kinetochores and activates SAC function. Simultaneously, TTK promotes error correction by phosphorylating several substrates.